Identification of competing endogenous RNAs of the tumor suppressor gene PTEN: A probabilistic approach

Kourosh Zarringhalam1, Yvonne Tay2,3, Prajna Kulkarni4

  • 1Department of Mathematics, University of Massachusetts Boston, Boston, MA, 02125, USA. kourosh.zarringhalam@umb.edu.

Scientific Reports
|August 12, 2017
PubMed

Insights

This study identifies key features of competing endogenous RNAs (ceRNAs) that regulate the tumor suppressor PTEN. Researchers developed a model to predict novel ceRNAs, validating TNRC6B as a PTEN ceRNA in prostate cancer cells.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • MicroRNAs (miRNAs) are crucial regulators of cellular processes.
  • Competing endogenous RNAs (ceRNAs) modulate miRNA activity, including regulation of the PTEN tumor suppressor gene.
  • Understanding ceRNA mechanisms and sequence features is vital for cancer research.

Purpose of the Study:

  • To identify and assess sequence-based features that enable transcripts to act as effective ceRNAs.
  • To develop a quantitative model for predicting ceRNAs targeting PTEN.
  • To validate predicted ceRNAs in human prostate cancer cell lines.

Main Methods:

  • Analysis of PAR-CLIP and RNA-Seq data to identify miRNA binding sites.
  • Calculation of probabilistic features based on binding site number and distribution.
  • Prediction and experimental validation of novel PTEN ceRNAs.

Main Results:

  • Identified key sequence and spatial features of miRNA target recognition.
  • Developed a predictive model for ceRNA activity.
  • Validated TNRC6B as a novel ceRNA of PTEN in prostate cancer cells.

Conclusions:

  • The developed approach can map ceRNA networks for critical cellular regulators.
  • This work provides novel insights into pathway crosstalk in cancer.
  • Understanding ceRNA networks offers potential for new cancer therapeutic strategies.